Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination wi...
Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors
About this item
Full title
Author / Creator
Publisher
United States: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
United States: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Simultaneous radiochemotherapy (RCT) is the treatment of choice for locally advanced head and neck cancers. In order to evaluate the toxicity and the survival rates, we investigated the use of a very aggressive combination protocol that included cisplatinum and paclitaxel combined with hyperfractionated-accelerated radiotherapy. The final results o...
Alternative Titles
Full title
Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_875561777
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_875561777
Other Identifiers
ISSN
1357-0560
E-ISSN
1559-131X,1357-0560
DOI
10.1385/MO:23:3:325
